PERCEPTIVE ADVISORS LLC – Apellis Pharmaceuticals, Inc. Transaction History
PERCEPTIVE ADVISORS LLC portfolio value:
$25.02M
portfolio value
PERCEPTIVE ADVISORS LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +14.04% | 45.1K shares | 10.49M | $68.3 | 366.4K |
| Q2 2022 | share | Decrease | -78.32% | -1.16M shares | -60.75M | $45.22 | 321.3K |
| Q1 2022 | share | Increase | +2.07% | 30K shares | 6.64M | $50.81 | 1.48M |
| Q4 2021 | share | Increase | +136.05% | 836.7K shares | 48.36M | $47.95 | 1.45M |
| Q3 2021 | share | Decrease | -6.98% | -46.16K shares | -21.51M | $32.96 | 615K |
| Q2 2021 | share | Increase | 0.00% | 661.16K shares | 41.78M | $63.2 | 661.16K |
| Q3 2020 | share | Decrease | -100.00% | -11.41K shares | -373K | $30.17 | 0 |
| Q2 2020 | share | 0.00% | 0 shares | 46K | $32.66 | 11.41K | |
| Q1 2020 | share | Increase | 0.00% | 11.41K shares | 327K | $26.79 | 11.41K |